BREITMEYER JAMES B 4
4 · Oncternal Therapeutics, Inc. · Filed Jan 5, 2024
Insider Transaction Report
Form 4
BREITMEYER JAMES B
DirectorPresident, CEO
Transactions
- Tax Payment
Common Stock
2024-01-03$0.50/sh−50,955$25,279→ 443,034 total - Tax Payment
Common Stock
2024-01-03$0.50/sh−4,485$2,225→ 15,426 total(indirect: By Spouse)
Holdings
- 196,544(indirect: By Trust)
Common Stock
- 733(indirect: By Children)
Common Stock
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units.